Background: MicroRNAsplayavitalroleincoronaryarterydisease.Abnormalex-pressionofmicroRNAshasbeenfoundtobeassociatedwiththeoccurrenceofCAD. Methods: WeidentifiedsignificantlydifferentiallyexpressedmicroRNAsinplasma between40patientswithCADand10controlswithNCAusingRNAsequencing.The differentiallyexpressedmicroRNAswereanalyzedforGeneOntology(GO)enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. Results: Fifty cDNA libraries were constructed and sequenced, and a total of 1871.82Mrawreadswereobtained,and2135microRNAswerefound.Compared to the expressed microRNAs of NCA controls, 159 microRNAs were differentially expressedinCADpatients,including119upregulatedmicroRNAsand40downregulated microRNAs. The top 10 upregulated miRNAs were miRand miR-6780a-5p. The target genes of differentially ex-pressedmicroRNAswererelatedtomanybasicbiologicalterms,suchasbiological process,cellularcomponent,andmolecularfunction.AccordingtotheKEGGpathwayanalysis,themostenrichedpathwaysofthedifferentiallyexpressedmicroRNAs ThisisanopenaccessarticleunderthetermsoftheCreativeCommonsAttributionLicense,whichpermitsuse,distributionandreproductioninanymedium, provided the original work is properly cited.
| INTRODUC TI ON
Coronary artery disease (CAD) is a common heart disease. It is a myocardial malfunction and structural lesion caused by coronary artery stenosis and poor blood supply. The occurrence of CAD is closely related to the degree and number of coronary artery stenoses. Hypertension, diabetes, obesity, smoking, and drinking are the main factors that induce this disease. [1] [2] [3] Clinically, it is often divided intostableangina(SA)andacutecoronarysyndrome(ACS).ACScan bedividedintounstableangina(UA),acutenon-ST-segmentelevationmyocardialinfarction(NSTEMI)andacuteST-segmentelevation myocardial infarction (STEMI), according to severity. STEMI and NSTEMIaretogetherknownasacutemyocardialinfarction(AMI). 4, 5 Coronary artery disease is one of the most fatal diseases in the world. 6, 7 Atherosclerosisplaysapivotalroleintheoccurrenceand progression of CAD. It is strongly associated with arterial stenosis because of the accumulation of atheromatous plaque, adipopexis, andextracellularmatrix.Coronarythrombosisoftenleadstoacute coronary events. Inflammation is involved in various stages of the formationanddevelopmentofatherogenesisplaque,andinflammatory factors produced in this process are predicted to be potential markers of CAD. They play a key role in coordinating the interactions of the cells during the development of atherogenesis. [8] [9] [10] [11] Inflammatory mediators involved in the function of some cells, including endothelial cells, macrophages, and T cells. They stimulate some signalling pathways in the onset and progression of atherosclerosis. 12, 13 TheycanberegulatedbymicroRNAs(miRNAs),whichare smallnon-codingRNAsthathaveemergedasimportantregulators in atherosclerosis. [14] [15] [16] [17] [18] MicroRNAsareaclassofsingle-strand,non-codingRNAswith a length of 18-22 bp that play a vital regulatory role in different cell development processes by downregulating the expression of their target genes. 19, 20 TheanalysisoftheexpressionofmicroRNA in blood, tissue, or cell samples provides important information for the study of the biological functions of these molecules. In recent years, researchers have developed many methods to detect the differences in the expression of microRNAs in some physiological and pathological processes, and they have found that the abnor-malexpressionofmicroRNAsisconnectedwiththeoccurrenceof cancer, 21 nervous disorders, 22, 23 diabetes, 24 and heart diseases. [25] [26] [27] Many studies have shown that microRNAs have some important regulatory effects in the cardiovascular system, including the heart, inflammatory response, angiogenesis, and metabolism. 20, [28] [29] [30] AbnormalexpressionofmicroRNAshasbeenfoundtoberelatedto theoccurrenceofCAD.
In this study, the differential expression of microRNAs in CAD patientsandnormalcoronaryartery(NCA)controlswasdetectedby high-throughputsequencing.WeexploredtheroleofmicroRNAsin CAD,andwefurtherexploredtherelationshipbetweenmicroRNAs andtheonsetandprogressionofCADtoprovidenewideasforthe diagnosisandtreatmentofCAD. 
| MATERIAL S AND ME THODS

| Study subjects
| Sample collection and processing
Two samples were taken before the coronary angiography surgery, onefortheextractionofwhole-bloodRNAandoneforthedetection of BNP and cTnI. Peripheral blood samples (6 mL) were taken fromtheanteriorelbowveinusingEDTAanticoagulanttubes,mixed gently up and down for 10 times, saved at 4°C, and subjected to plasma separation within 1 hour. The blood samples were centrifuged at 800 g for 10 minutes, and the plasma was transferred to a 1.5mLcentrifugetube(RNase-free).TotalRNAwasobtainedwith anRNeasyKit(TianGene),andRNAintegritywasassessedusingan AgilentBioanalyzer2100system(AgilentTechnologies).
| Library construction and highthroughput sequencing
After screening test samples, a library of small RNAs was con-structedusinganIlluminaTruSeqSmallRNASamplePrepKit,which 
| Identification of differentially expressed genes
| Gene ontology and KEGG enrichment analysis
Gene ontology analysis was carried out to determine the potential biological process terms of the differentially expressed genes in GO annotations. 31 Pathway analysis was utilized to find the significant pathways of the differentially expressed genes according to the KEGG database. 32 Fisher's exact test was applied to evaluate whether the GO terms or the KEGG pathways were enriched amongthedifferentiallyexpressedgenes,andP<.05wassetasthe threshold for. 
| Quantitative real-time PCR
| Statistical analysis
| RE SULTS
| Clinical characteristics of subjects
Atotalof40CADpatientsand10NCAcontrolswererecruitedinthe study.Theclinicalfeaturesofthe50subjectsinthisstudyareshown
in Table 1 . There was a higher prevalence of diabetes and total cholesterol(TC)intheUAgroupthanintheothergroups(P=.0435and P = .0045, respectively), whereas high-density lipoprotein cholesterol(HDL-C)levelintheNSTEMIpatientswassignificantlyhigher than in the other groups (P < .001). The cardiac troponin I (cTnI) levels in the UA, NSTEMI, and STEMI patients were significantly higher thanintheNCAandSAgroups(P < .001). There were no significant differencesinage,sex,smoking,drinking,systolicBP,diastolicBP, hypertension, triglycerides (TG), or low-density lipoprotein cholesterol(LDL-C)betweentheCADpatientsandNCAcontrols. 
| Overview of the sequencing data
| Differentially expressed microRNAs in plasma
MicroRNAs were analyzed with strict data quality control, and a total of 2135 microRNAs were found. To systematically study the levelofmicroRNAexpressionassociatedwithCAD,40patientswith
CADand10NCAcontrolswereanalyzedinthisstudy.Thediffer-encesbetweentheCADpatientsandtheNCAcontrolsareshown in Figure 2 . The blue and red in the picture indicate that the relative expressionwasreducedandraised,respectively. 
| Gene ontology and KEGG pathway analyses
Gene ontology and KEGG pathway analysis showed that genes were sorted by hierarchical categories according to biological process, cellular component, and molecular function.
AmongtheidentifiedmRNAs,19243geneswererelatedtobiological function ( Figure 6 ). The enriched GO terms of these potential targets included many biological events. The most enriched path- 
| qRT-PCR validation of microRNA expression
ToconfirmthesequencingdataofmicroRNAexpressionlevels,six upregulatedmicroRNAs(has-miR-126-5p,has-miR-20a-5p,has-miR-22-3p, has-miR-29a-3p, has-miR-30e-5p, and has-miR-93-5p) and two downregulated microRNAs (has-miR-3184-3p and has-miR-671-3p) were randomly selected. We confirmed the microRNA expressionintheplasmaofCADpatients(n=80)andNCAcontrols (n=20)byqRT-PCRusingU6snRNAastheinternalcontrolwiththe 
| ROC analysis
ROC analysis was done to evaluate the diagnostic value of some differentially expressed microRNAs that were randomly selected for differentiatingbetweenCADpatientsandNCAcontrols.MicroRNAs 
| D ISCUSS I ON
Heart disease is the main cause of death for both males and females and is a great burden to some countries, which includes the cost of health care services, medications, and lost productivity. [33] [34] [35] [36] Before vessel obstruction, the vascular wall has a plaque for a long time,
and several cytokines are involved in all stages of the formation and progressionofatherogenicplaque,whichprovidesapossibilityfor the prediction and early diagnosis of cardiovascular adverse events.
There is a lack of good biomarkers that could be used in early clinical diagnosis, clinical risk stratification, and evaluation of the prognosis ofCAD,andthereisagreatclinicaldemandforreliablenon-invasive biomarkersforCAD. 37, 38 ManystudieshavefoundthatmicroRNAsareimportantregulators of the onset and progression of coronary artery disease.
Inaddition,somereportshaveshownthatsomemicroRNAscan beusedasdiagnosticorprognosticmarkersforCAD.MicroRNAs are a novel group of conserved non-coding, single-strand small RNAsthatregulategeneexpressionaftertranscription,leadingto translationinhibitionormRNAdegradation. 39 Many studies have
shown that microRNAs participate in many biological processes andspeculatethattheyregulatetheexpressionof1/3ormoreof
the genes in animals. 40, 41 MicroRNAsarenotonlywidelyinvolved in important life processes, such as the normal growth, development, and metabolism of the body, but they also play an important regulatory role in the onset and progression of many diseases.
PlasmaorserummicroRNAscanbebiologicalindicatorsforearly clinical diagnosis, and further exploration of microRNAs in the pathogenesis of some diseases has gotten increasing attention globally. These molecules provide a new research field to study earlyclinicaldiagnosis,clinicalrisk-stratifieddiagnosis,andevalu-ationoftheprognosisofCAD.
We reviewed the relevant literature on microRNAs related to cardiovascular disease and compared the previous results with ours.
OnestudyshowedthatmiR-126-5pwasnotsignificantlyupregulated
F I G U R E 2 HierarchicalclusteringofmicroRNAsinCADpatientsandNCAcontrols.AS1-ASX:NCAcontrols;BS1-BSX:SApatients;CS1-CSX:UApatients;DS1-DSX:NSTEMIpatients;ES1-ESX:STEMIpatients ordownregulatedinCADpatients,butthelevelofmiR-126-5pwas significantly increased in patients whose LDL cholesterol was high. 42 Another study indicated that circulating miR-126-5p is a potential biomarker for predicting type 2 diabetes and diabetic CAD. 43 One studyshowedthatthelevelofmiR-146a/bwasobservablyincreased intheCADgroupcomparedwiththenon-CADgroup. 44 TheSNPin miR-146aandrs2910164G>Cwassignificantlyassociatedwithanin-creasedriskforCAD. 45 Anotherreporthasshownthatearlygrowth response2(EGR2)isregulatedby8microRNAs,includingmiR-150.
Itmightplayimportantrolesinpatientsbeforeandafteroff-pump coronaryarterybypass(OPCAB)surgeryviatheregulationofassociated genes. 46 Many studies have shown that miR-17-5p is an im-portantregulatorintheG1/Sphasecellcycletransition. 47 miR-17-5p
is associated with breast cancer, 48, 49 lung cancer, 50 liver cancer, 51
gastric cancer, 52 pancreatic cancer, 53 and multiple sclerosis 54 and may have a role in the onset and progression of heart failure. 55 In miR-423-5pcomparedwithhealthycontrols. 59 In this study, we found Our study was on the microRNA expression profiles in the Chinese Hakka population, but there are still some shortcomings to our research. The number of subjects in this study was low. In addition, there may be differences in the results of patients from different regions and races. Therefore, these results need to be verified in alargernumberofpeople.Again,thefunctionsofthesemicroRNAs
have not yet been determined. More detailed studies are needed to determinethebiologicaleffectsofthemicroRNAs.
| CON CLUS IONS
This study comprehensively identified and analyzed microRNA expression in CAD patients using RNA sequencing. The results 
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